<< Back to News

System Formulary Update
Trastuzumab-qyyp (Trazimera)

Situation

Trastuzumab-qyyp (Trazimera) 150 mg/vial (SDV) and 420 mg/vial (MDV) for injection was approved for addition to the health system formulary at the June 2021 System Pharmacy and Therapeutics Committee meeting.

Background

The following medication was reviewed: Trastuzumab-qyyp (Trazimera) 150 mg/vial (SDV) and 420 mg/vial (MDV) for injection

Assessment/Recommendation

Change effective: Tuesday, July 27, 2021 

System P&T voted to include the following products on the UNC Health Medication Formulary:

• Trastuzumab-qyyp (Trazimera) 150 mg/vial (SDV) for injection
• Trastuzumab-qyyp (Trazimera) 420 mg/vial (MDV) for injection

Note: Stock of this formulary product may vary at individual entities